Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.74EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.74ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.74ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.74EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.74EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.74ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.74ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BM.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BM.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BM.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
BM.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BM.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-5161.21China
BM.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3181.36China
BA.5.2.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BE.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BE.1.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BE.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BE.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAZEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XAZEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used